pd 98059 and cimadronate

pd 98059 has been researched along with cimadronate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amano, S; Inagaki, Y; Kikuchi, S; Ohno, S; Okamoto, T; Takeuchi, M; Yamagishi, S; Yoshimura, A1
Harada, A; Hirade, K; Ito, H; Kato, K; Kozawa, O; Matsuno, H; Oiso, Y; Tokuda, H1

Other Studies

2 other study(ies) available for pd 98059 and cimadronate

ArticleYear
Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro.
    Biochemical and biophysical research communications, 2002, Sep-20, Volume: 297, Issue:2

    Topics: Animals; Cells, Cultured; Diphosphonates; Endothelial Growth Factors; Endothelium, Vascular; Flavonoids; Glycation End Products, Advanced; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Neovascularization, Pathologic; NF-kappa B; Polyisoprenyl Phosphates; Promoter Regions, Genetic; Sesquiterpenes; Transcription Factor AP-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002
Incadronate amplifies prostaglandin F2 alpha-induced vascular endothelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity.
    The Journal of biological chemistry, 2003, May-23, Volume: 278, Issue:21

    Topics: Alkyl and Aryl Transferases; Animals; Cell Line; Cloprostenol; Cycloheximide; Cyclooxygenase Inhibitors; Dinoprost; Diphosphonates; Endothelial Growth Factors; Enzyme Activation; Enzyme Inhibitors; Farnesyltranstransferase; Flavonoids; Gene Expression; Indoles; Indomethacin; Intercellular Signaling Peptides and Proteins; Lymphokines; Maleimides; Mice; Osteoblasts; Prostaglandins F, Synthetic; Protein Kinase C; RNA, Messenger; Sodium Fluoride; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003